Effect of statin use within the first 24 hours of admission for acute myocardial infarction on early morbidity and mortality

American Journal of Cardiology

Volumn 96, Issue 5, 2005, Pages 611-616

  Fonarow, Gregg C ^a   Wright, R Scott ^c   Spencer, Frederick A ^d   Fredrick, Paul D ^e   Dong, Wei ^g   Every, Nathan ^f   French, William J ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HARBOR UCLA MEDICAL CENTER   (United States)

^c MAYO CLINIC   (United States)

^d UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^e Ovation Research Group   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

^g GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CARDIOGENIC SHOCK; DRUG EFFECT; FEMALE; HEART ARREST; HEART ARRHYTHMIA; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; RECURRENT DISEASE; REGISTER; RISK ASSESSMENT; RISK REDUCTION; RUPTURE; TREATMENT OUTCOME;

AGED; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HOSPITAL MORTALITY; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MORBIDITY; MYOCARDIAL INFARCTION; OBSERVATION; ODDS RATIO; PATIENT ADMISSION; PROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; UNITED STATES;

EID: 23944497531     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2005.04.029     Document Type: Article

References (9)

1. J.A. Osborne, P.H. Lento, M.R. Siegfried, G.L. Stahl, B. Fusman, A.M. Lefer Cardiovascular effects of acute hypercholesterolemia in rabbits. Reversal with lovastatin treatment J Clin Invest 83 1989 465 473
2. A.M. Lefer, B. Campbell, Y.K. Shin, R. Scalia, R. Hayward, D.J. Lefer Simvastatin preserves the ischemic-reperfused myocardium in normocholesterolemic rat hearts Circulation 100 1999 178 184
3. N.R. Every, P.D. Frederick, M. Robinson, J. Sugarman, L. Bowlby, H.V. Barron A comparison of the national registry of myocardial infarction 2 with the cooperative cardiovascular project J Am Coll Cardiol 33 1999 1886 1894
4. D.B. Rubin Estimating causal effects from large data sets using propensity scores Ann Intern Med 127 1997 757 763
5. P. Di Napoli, A. Antonio Taccardi, A. Grilli, R. Spina, M. Felaco, A. Barsotti, R. De Caterina Simvastatin reduces reperfusion injury by modulating nitric oxide synthase expression an ex vivo study in isolated working rat hearts Cardiovasc Res 51 2001 283 293
6. U. Laufs, V. La Fata, J. Plutzky, J. Liao Upregulation of endothelial nitric oxide synthase by HMG-CoA reductase inhibitors Circulation 97 1998 1129 1135
7. Y. Kureishi, Z. Luo, I. Shiojima, A. Bialik, D. Fulton, D.J. Lefer, W.C. Sessa, K. Walsh The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals Nat Med 6 2000 1 7
8. S. Hayashidani, H. Tsutsui, T. Shiomi, N. Suematsu, S. Kinugawa, T. Ide, J. Wen, A. Takeshita Fluvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, attenuates left ventricular remodeling and failure after experimental myocardial infarction Circulation 105 2002 868 873
9. B. Kwak, F. Mulhaupt, S. Myit, F. Mach Statins as a newly recognized type of immunomodulator Nat Med 6 2000 1399 1402